Chase Knickerbocker Analyst PerformanceSenior Equity Research Analyst - Healthcare at Craig HallumChase Knickerbocker is a stock analyst at Craig Hallum in the medical sector, covering 17 publicly traded companies. Over the past year, Chase Knickerbocker has issued 20 stock ratings, including strong buy, buy, and hold recommendations. While full access to Chase Knickerbocker's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Chase Knickerbocker's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions. Analyst Rankings, Coverage, and Performance StatisticsAnalyst RankingSubscribe to MarketBeat All Access for the analyst's recommendation accuracy rating MarketBeatAverage Return00.00% 12-Month ROISuccess Rate00.00% Profitable RatingsTotal Ratings20 Last 0 YearsBuy Recommendations95.00% 19 Buy RatingsCompanies Covered17 Unique Companies Ratings Distribution20RatingsDistribution of strong buy, buy, hold, and sell ratings by Chase Knickerbocker.RatingPercentageCount Strong Buy5.0%1 ratings Buy90.0%18 ratings Hold5.0%1 ratings Sell0.0%0 ratingsOut of 20 total stock ratings issued by Chase Knickerbocker at Craig Hallum, the majority (90.0%) have been Buy recommendations, followed by 5.0% Strong Buy and 5.0% Hold.Best & Worst CallsThis analyst does not have any ratings with enough history to determine best and worst calls.Exchange CoverageExchangePercentageCountNASDAQ82.4% of companies on NASDAQ14 companiesNYSE11.8% of companies on NYSE2 companiesNYSEAMERICAN5.9% of companies on NYSEAMERICAN1 companyChase Knickerbocker, an analyst at Craig Hallum, currently covers 17 companies listed on NASDAQ, NYSE and NYSEAMERICAN, with the majority traded on NASDAQ.Coverage FocusSector IconSectorPercentageMedical17 companies100.0%Chase Knickerbocker of Craig Hallum specializes in stock coverage within the Medical sector.Coverage IndustriesIndustryPercentageMED - DRUGS6 companies35.3%MED - BIOMED/GENE5 companies29.4%MEDICAL INFO SYS2 companies11.8%MED INSTRUMENTS2 companies11.8%ELECTROMEDICAL EQUIPMENT1 company5.9%SURGICAL & MEDICAL INSTRUMENTS1 company5.9% About Chase KnickerbockerChase focuses on Specialty Pharmaceutical, Biotech, and Medical Technology companies. He brings a unique commercial perspective to his coverage, as he held several field sales roles at Stryker earlier in his career, prior to joining Craig-Hallum. Chase received his BA in Finance from the University of Minnesota Crookston.Follow on LinkedIn Chase Knickerbocker's Ratings History at Craig Hallum Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 4 Years 5 Years All Time Timeframe Start Date End Date All Ratings Strong Buy Buy Hold Sell Rating Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.Available with a MarketBeat All Access Subscription12-Month ROIUpgrade to All Access to use the All ROI Filter Export to Excel CompanyReport DateActionReport Date Price12-MonthPrice TargetRating12-MonthPrice & ROIDetailsHROWHarrow9/23/2025Boost Price Target$49.35$64.00Buy$0.0000.00% ROIINDVIndivior8/27/2025Boost Price Target$24.53$34.00Buy$0.0000.00% ROISCPHscPharmaceuticals8/25/2025Downgrade$5.53$6.00Hold$0.0000.00% ROIFENCAdherex Technologies8/15/2025Boost Price Target$8.55$14.00Buy$0.0000.00% ROIPYPDPolyPid8/14/2025Reiterated Rating$3.41$13.00Buy$0.0000.00% ROIDMACDiaMedica Therapeutics7/18/2025Boost Price Target$3.93$11.00Buy$0.0000.00% ROIBFLYButterfly Network7/1/2025Initiated Coverage$2.00$3.00Buy$0.0000.00% ROIINDVIndivior6/30/2025Boost Price Target$13.95$22.00Buy$0.0000.00% ROINRXSNeurAxis6/16/2025Upgrade$2.58$7.00Strong-Buy$0.0000.00% ROIPHATPhathom Pharmaceuticals6/9/2025Boost Price Target$8.73$17.00Buy$0.0000.00% ROIFENCAdherex Technologies5/14/2025Boost Price Target$6.51$13.00Buy$0.0000.00% ROIETONEton Pharmaceuticals5/14/2025Boost Price Target$17.09$28.00Buy$0.0000.00% ROIBVSBioventus5/7/2025Set Price Target$6.55$15.00Buy$0.0000.00% ROIETONEton Pharmaceuticals3/19/2025Boost Price Target$14.70$26.00Buy$0.0000.00% ROIXERSXeris Biopharma3/7/2025Boost Price Target$4.24$6.50Buy$0.0000.00% ROIMDWDMediWound2/28/2025Initiated Coverage$16.23$39.00Buy$0.0000.00% ROIIRWDIronwood Pharmaceuticals1/22/2025Lower Price Target$3.79$8.00Buy$0.0000.00% ROIDCTHDelcath Systems1/17/2025Boost Price Target$13.98$21.00Buy$0.0000.00% ROIKRMDKORU Medical Systems1/17/2025Boost Price Target$4.15$6.00Buy$0.0000.00% ROIXTNTXtant Medical10/18/2024Set Price Target$0.58$1.50Buy$0.0000.00% ROI Stock Forecasts and Research Tools Today's Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top-Rated Stocks Top Rated Stocks Top-Rated Dividend Stocks Top-Rated Small-Cap Stocks Top-Rated Tech Stocks Most-Upgraded Stocks Most-Downgraded Stocks Lowest-Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter Price Forecasts for Popular Stocks Alphabet (Google) Stock ForecastAmazon Stock ForecastApple Stock ForecastMeta (Facebook) Stock ForecastMicrosoft Stock ForecastNetflix Stock ForecastNvidia Stock ForecastTesla Stock Forecast Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
